A0A024R2B3 (A0A024R2B3_HUMAN) Homo sapiens (Human)

Apoptosis regulator Bcl-2 UniProtKBInterProInteractive Modelling

239 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: P10415; Pan troglodytes: A0A6D2Y6S1, H2QEM8

Available Structures

33 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Bcl-2 complex with Beclin 1 BH3 domain Heteromer
P10415; Q14457;
1-206
Assess
Bcl-2 complex with Beclin 1 T108D BH3 domain Heteromer
P10415; Q07817; Q14457;
1-206
Assess
Bcl2-inhibitor complex Heteromer
P10415;
7-207
Assess
Bcl-2 complex with Beclin 1 BH3 domain Heteromer
P10415; Q14457;
9-207
Assess
Crystal structure of Bcl-2 in complex with HBx-BH3 motif Heteromer
P10415; Q99HR6;
6-203
Assess
Bcl-2 alpha beta-1 LINEAR complex Heteromer
O43521; P10415; Q07817;
8-204
Assess
Crystal structure of a computationally designed protein (LD3) in complex with BCL-2 Heteromer
P02649; P10415;
SO4;9-205
Assess
Crystal structure of BCL-2 in complex with a BAX BH3 peptide Heteromer
P10415; Q07813;
10-206
Assess
Bcl-2 alpha beta-1 complex Heteromer
O43521; P10415; Q07817;
10-204
Assess
Structure of human Bcl-2 in complex with PUMA BH3 peptide Heteromer
P10415; Q07817; Q9BXH1;
10-203
Assess
Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based li…monomer43B;3-207
Assess
HUMAN BCL-2, ISOFORM 1monomer3-207
Assess
Solution structure of the anti-apoptotic protein Bcl-2 complexed with an acyl-sulfonamide-based lig…monomer43B;3-207
Assess
HUMAN BCL-2, ISOFORM 2monomer3-207
Assess
Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based li…monomerLIU;3-207
Assess
Bcl_2-Navitoclax Analog (without Thiophenyl) Complexmonomer1XV;6-204
Assess
Crystal Structure of Chimaeric Bcl2-xL and Phenyl Tetrahydroisoquinoline Amide ComplexmonomerDRO;9-206
Assess
Bcl_2-Navitoclax Analog (with Indole) Complexmonomer1Y1;8-204
Assess
Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based li…monomerLI0;8-204
Assess
crystal structure of BCL-2 F104L mutation with venetoclaxmonomerLBM;PEG;8-203
Assess
Bcl_2-Navitoclax (ABT-263) Complexmonomer1XJ;9-204
Assess
Crystal structure of Bcl-2 in complex with prodrug ABBV-167monomerXZD;9-204
Assess
Crystal Structure of human Bcl-2 in complex with a small molecule inhibitor targeting Bcl-2 BH3 dom…monomer1E9;9-204
Assess
Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746monomerF3Q;9-203
Assess
crystal structure of BCL-2 with venetoclaxmonomerLBM;2PE;9-203
Assess
crystal structure of BCL-2 G101A mutation with venetoclaxmonomerLBM;PEG;9-203
Assess
crystal structure of BCL-2 G101V mutation with S55746monomerF3Q;9-203
Assess
crystal structure of BCL-2 G101V mutation with venetoclaxmonomerLBM;PEG;CL;9-203
Assess
HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITORmonomer398;9-203
Assess
Structure of human Bcl-2 in complex with analogue of ABT-737monomerJ1H;10-203
Assess
Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compoundmonomerJ1Q;ACT;10-203
Assess
Structure of human Bcl-2 in complex with ABT-263monomer1XJ;10-203
Assess
Structure of human Bcl-2 in complex with fragment/ABT-263 hybridmonomerJ1T;11-203
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.705jsn.1.A7-207
100.00
Assess

Alignments